Discontinuation of secondary prevention medication after myocardial infarction - the role of general practitioners and patients. [electronic resource]
Producer: 20140611Description: w13896 p. digitalISSN:- 1424-3997
- Adrenergic beta-Antagonists -- therapeutic use
- Adult
- Aged
- Aged, 80 and over
- Angiotensin Receptor Antagonists -- therapeutic use
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Aspirin -- therapeutic use
- Clopidogrel
- Female
- General Practice -- methods
- Guideline Adherence -- statistics & numerical data
- Humans
- Male
- Middle Aged
- Myocardial Infarction -- drug therapy
- Platelet Aggregation Inhibitors -- therapeutic use
- Practice Guidelines as Topic
- Secondary Prevention -- methods
- Surveys and Questionnaires
- Ticlopidine -- analogs & derivatives
- Assessment of Medication Adherence
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.